Roche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19 products and a number of its cancer drugs.
The at-home testing industry, from Covid to cancer, may be worth over $2 billion by 2025 : Rashtra News #athome #testing #industry #Covid #cancer #worth #billion The at-home testing market is bigger than just Covid tests, and it's bigger than over-the-counter pregnancy tests.In fact, the emerging marketplace of consumer-initiated lab testing may be worth more
In this article, we will discuss the 15 biggest Swiss companies. If you want to skip our analysis, you can proceed to the section highlighting the 5 Biggest Swiss Companies. Economy of Switzerland According to a report by the Federal Council of Switzerland, the Swiss GDP growth is projected to remain sluggish at 1.1% in […]
Ocrelizumab is currently the only approved treatment for primary progressive multiple sclerosis and relapsing multiple sclerosis with a twice-yearly dosing regimen that patients are likely to prefer over alternatives that typically involve monthly injections or daily doses, Roche officials said